Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma

• Lei Yang,

  Roles Data curation, Formal analysis, Writing – original draft

  Affiliation Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Kien Pham,

  Roles Writing – review & editing

  Affiliation Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Yibo Xi,

  Roles Writing – review & editing

  Affiliation Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Qunfeng Wu,

  Roles Methodology

  Affiliation Department of Pathology and Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America

  ⨯
• Dongfang Liu,

  Roles Methodology

  Affiliation Department of Pathology and Laboratory Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America

  https://orcid.org/0000-0002-7295-8088

  ⨯
• Keith D. Robertson,

  Roles Methodology

  Affiliation Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Chen Liu

  Roles Funding acquisition, Investigation, Writing – review & editing

  * E-mail: chen.liu@yale.edu

  Affiliation Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America

  https://orcid.org/0009-0003-0430-6146

  ⨯